Skip to content
Lower risk Medical device recall · FDA · Published April 21, 2020

Bio-Rad BioPlex 2200 Syphilis Kit Has Increased RPR Reactivity - Recall

Bio-Rad recalls BioPlex 2200 Syphilis Total & RPR kit due to potential increased RPR reactivity in specific lots. Affected kits may produce inaccurate results for syphilis testing.

🇺🇸 FDA recall #Z-2982-2020Medical deviceBio-Rad ›
Take action

Contact the company

Recalling firmBio-Rad Laboratories, Inc.6565 185th Ave Ne · Redmond, WA 98052-5039
✎ GovInfoNow plain-language explainer

What happened, in plain English

Bio-Rad is recalling certain lots of their BioPlex 2200 Syphilis Total & RPR kit because the RPR reactivity level is higher than expected. This could lead to inaccurate syphilis test results, which is important for proper diagnosis and treatment. Read more at govinfonow.com/recall/65348-bio-rad-bioplex-2200-syphilis-kit-has-increased-rpr-reactivity.

Source Summary by GovInfoNow · govinfonow.com/recall/65348-bio-rad-bioplex-2200-syphilis-kit-has-increased-rpr-reactivity · Updated August 19, 2026 · FDA enforcement record: FDA #Z-2982-2020

Cite this page

“Bio-Rad BioPlex 2200 Syphilis Kit Has Increased RPR Reactivity - Recall.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/65348-bio-rad-bioplex-2200-syphilis-kit-has-increased-rpr-reactivity. Based on FDA recall #Z-2982-2020 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2982-2020%22&limit=1).

Why it’s dangerous

The kit's RPR reactivity level is higher than intended, which can cause false positive results in syphilis testing. This means the test might incorrectly indicate that someone has syphilis when they do not, or vice versa.

Who’s affected

People who use the BioPlex 2200 Syphilis Total & RPR kit for syphilis testing are affected. Those who have recently used the kit with the specific UDI 03610520653012 and lot numbers 301142 or later are most at risk.

How to tell if you have this one

Check the kit's unique device identifier (UDI) 03610520653012 and lot numbers. The affected kits will have lot numbers starting from 301142 or later.

  • Brand
    Bio-Rad
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check Kit Details

    Look for the unique device identifier (UDI) 03610520653012 and lot numbers starting from 301142 or later on the kit.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 41 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: nationwideWYSouth Dakota: named in the noticeSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: named in the noticeKSArkansas: nationwideARTennessee: nationwideTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “Worldwide distribution - US Nationwide distribution including in the states of AK, AL, AZ, CA, CO, CT, FL,GA, HI, IA, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, NC, ND, NE, NJ, NV, NY, OH, OK, OR, PA, PR, RI, SC, SD, TX, UT, VA, WA,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, California, Colorado, Connecticut, Florida, Georgia, Hawaii, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Jersey, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Rhode Island, South Carolina, South Dakota, Texas, Utah, Virginia, Washington, West Virginia, Wisconsin.

Recall timeline

FDA published this recall 5 months after the firm started it.

1. Firm started the recall: Apr 21, 202012. FDA classified it Class II: Sep 18, 202023. Published in FDA’s Enforcement Report: Sep 30, 202032020
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

What should I do if I have this kit?

Check the kit's UDI and lot number. If it matches the affected details, you should stop using it and contact Bio-Rad for further instructions.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2982-2020 (April 21, 2020) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2982-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA